Description
Phentermine-d
5 (CRM) is intended for use as an internal standard for the quantification of phentermine by GC- or LC-mass spectrometry. Phentermine is an α-methylated amphetamine that activates trace amine associated receptor 1 (TAAR1, EC
50 = 5.47 μM). It potently stimulates the release of norepinephrine (IC
50 = 39.4 nM), with less effect on the release of dopamine and serotonin (IC
50s = 262 and 3,511 nM, respectively). Primarily through these actions, phentermine suppresses appetite and augments fat metabolism, supporting usefulness in ameliorating obesity.
References
[1] SEAN MANNING Nicholas F Andrea Pucci. Pharmacotherapy for obesity: novel agents and paradigms.[J]. Therapeutic Advances in Chronic Disease, 2014, 5 3: 135-148. DOI:
10.1177/2040622314522848[2] NADIA FUCCI Nadia D G. Adulterants encountered in the illicit cocaine market[J]. Forensic science international, 1998, 95 3: Pages 247-252. DOI:
10.1016/s0379-0738(98)00102-9